论文部分内容阅读
目的:调查分析对于中老年2型糖尿病合并脑梗塞的临床治疗方法及其效果。方法:调查研究在2013年1月1日到2014年9月1日期间来我院进行诊断治疗的88例2型糖尿病合并脑梗塞的老年患者,按照入院时间,随机分成对照组和治疗组,各有44例,对照组采用常规治疗,治疗组加用奥扎格雷钠和血塞通治疗,评估治疗效果。结果:治疗结束后,治疗组的评分为(11.2±2.1)分,显著低于对照组的(15.6±4.6)(P<0.05);治疗组的治疗有效率为93.18%,显著高于对照组的72.73%(P<0.05)。结论:采用奥扎格雷钠和血塞通联合治疗中老年2型糖尿病合并脑梗塞效果显著,明显提高患者神经功能,利于患者预后,优势较大。
Objective: To investigate the clinical treatment of middle-aged and elderly patients with type 2 diabetes mellitus complicated with cerebral infarction and its effects. Methods: A total of 88 elderly patients with type 2 diabetes mellitus complicated with cerebral infarction who were diagnosed and treated in our hospital from January 1, 2013 to September 1, 2014 were randomly divided into control group and treatment group according to the time of admission. Each 44 cases, the control group with conventional treatment, the treatment group plus sodium ozagrel and Xuesaitong treatment, to assess the therapeutic effect. Results: At the end of treatment, the score of the treatment group was (11.2 ± 2.1) points, which was significantly lower than that of the control group (15.6 ± 4.6) (P <0.05). The treatment effective rate was 93.18% in the treatment group, which was significantly higher than that in the control group Of 72.73% (P <0.05). Conclusion: Ozagrel sodium and Xuesaitong combined treatment of middle-aged and elderly patients with type 2 diabetes mellitus and cerebral infarction have a significant effect, significantly improve the neurological function of patients, which will benefit the prognosis of patients with greater advantages.